Clinical Endocrinology Cases: Pituitary OmpathStudy

Study Clinical Endocrinology Cases: Pituitary Tumour, PCOS, Type 1 Diabetes with clear, structured coverage of the key concepts in Endocrine and Metabol...

Summary This document presents four detailed clinical endocrinology cases, each accompanied by questions and answers designed to test understanding of diagnosis, investigation interpretation, and management. The cases cover a pituitary macroadenoma causing acromegaly and hypogonadism, Polycystic Ovary Syndrome (PCOS) with its characteristic hormonal and physical findings, a Type 1 Diabetes patient with poor self-monitoring leading to a discrepancy in glycaemic control indicators, and a Hyperosmolar Hyperglycaemic State (HHS) presenting as a diabetic emergency. Each case includes patient history, relevant investigations, and specific clinical questions with expert answers. Key Points Acromegaly: Characterized by elevated Growth Hormone (GH) that does not suppress with glucose, leading to somatic overgrowth and potential mass effects from pituitary tumors. Pituitary Tumour Extension: Suprasellar extension can cause visual field defects like bitemporal hemianopia due to optic chiasm compression. Hyperprolactinemia: Can suppress GnRH pulsatility, leading to secondary hypogonadism, manifesting as low LH, FSH, and testosterone. Polycystic Ovary Syndrome (PCOS): Diagnosed by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries on ultrasound, often associated with an elevated LH:FSH ratio. Hirsutism in PCOS: Directly caused by elevated testosterone levels due to hyperandrogenism. Type 1 Diabetes Monitoring: HbA1c provides a 2-3 month average of blood glucose, while single glucose readings reflect immediate control, creating potential discrepancies. Poor Glucose Monitoring Risks: Can lead to undetected long-term complications from hyperglycemia or acute dangers from hypoglycemia. Hyperosmolar Hyperglycaemic State (HHS): A diabetic emergency characterized by severe hyperglycemia, marked hyperosmolality, profound dehydration, and absence of significant ketosis, often seen in Type 2 diabetes. HHS Pathophysiology: Sufficient residual insulin inhibits lipolysis and ketogenesis, distinguishing it from DKA. HHS Management: Prioritizes careful IV fluid resuscitation and gradual insulin infusion to correct dehydration and hyperglycemia, while monitoring electrolytes and avoiding rapid osmolality shifts. Detailed Notes Case 1 — Pituitary Tumour / Acromegaly Q: A 40-year-old man consults his family doctor complaining of impotence. His wife has noticed excessive sweating at rest and coarsening of his facial features. He recently needed larger shoes as his old ones became uncomfortable. The GP found mild hypotension and glycosuria, and referred him to the endocrine clinic. Visual fields showed bitemporal hemianopia. Pituitary MRI showed a tumour with suprasellar extension. Investigations: Investigation Result ------------------------------- ---------------------- Plasma Na 8.5 mmol/L → 2 hrs later: 11.5 mmol/L Serum Growth Hormone 20 mU/L → minimum 20 mU/L 9 am Serum Prolactin 800 mU/L Testosterone 11 mmol/L LH 2.0 mU/L FSH 1.5 mU/L Free T4 16 pmol/L TSH 0.8 mU/L Cortisol 400 nmol/L Cortisol 30 min after tetracosactide 700 nmol/L What is the most likely diagnosis? Acromegaly due to a GH-secreting pituitary macroadenoma with suprasellar extension. What is the significance of the growth hormone levels? A GH level that fails to suppress below 1 µg/L (or remains elevated at ≥20 mU/L) after glucose load confirms acromegaly — normal GH should suppress with rising glucose. How do you explain the low LH and FSH despite the elevated prolactin? The tumour causes hyperprolactinaemia, which suppresses GnRH pulsatility, leading to secondary hypogonadism (low LH, FSH, and testosterone) — explaining the impotence. What does the visual field defect indicate? Bitemporal hemianopia indicates compression of the optic chiasm by the suprasellar extension of the pituitary tumour. Is there adrenal insufficiency in this patient? No. Cortisol of 400 nmol/L rising to 700 nmol/L after tetracosactide (short Synacthen test) indicates intact HPA axis — a rise 550 nmol/L (or 200 nmol/L above baseline) is normal. Case 2 — Polycystic Ovary Syndrome (PCOS) Q: A young woman consults her doctor because she is embarrassed by excess hair on her upper lip, lower abdomen, and thighs. She is mildly obese and has irregular periods. Investigations: Serum Testosterone: 3.5 nmol/L Early morning LH: 14 units/L FSH: 3 units/L Ultrasound of ovaries: multiple cysts present bilaterally What is the most likely diagnosis? Polycystic Ovary Syndrome (PCOS). What is the significance of the LH:FSH ratio? An LH:FSH ratio 2:1 (here ~4.7:1) is characteristic of PCOS, reflecting dysregulated GnRH pulsatility favouring LH secretion. What is causing the hirsutism and irregular periods? Elevated testosterone (hyperandrogenism) causes hirsutism. Chronic anovulation due to disordered gonadotrophin secretion causes irregular periods. What would be your first-line management? Lifestyle modification (weight loss) is first-line. Combined oral contraceptive pill (COCP) addresses irregul
View on OmpathStudy